Glympse Bio Inc.

Sunbird Bio snaps up Glympse Bio for protein-based diagnostics

Glympse Bio, developer of an injectable diagnostic platform, has been acquired by Sunbird Bio, which plans to point the companies' resources toward a new blood ...

Glympse Bio Company Profile 2024: Valuation, Investors, Acquisition

Glympse Bio · Glympse Bio Overview · Year Founded. 2015. Year Founded · Status. Acquired/Merged · Employees. 16. Employees · Latest Deal Type. M&A · Latest ...

Glympse Bio - Crunchbase Company Profile & Funding

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

Sunbird Bio Merges with Glympse Bio to Accelerate Development of ...

The merged company, which will operate as Sunbird Bio, Inc., brings together two leaders in the protein diagnostics field with the ...

Glympse Bio, Inc. - CMOCRO

Glympse Bio is pioneering the development of disruptive, non-invasive technology to directly query disease activity inside the body.

Glympse Bio (Sunbird Bio)

The company's technology uses proprietary nanoparticles that interrogate the body for certain disease states and then carry the message to the urine for ...

Glympse Bio Inc - Company Profile and News - Bloomberg Markets

Company profile page for Glympse Bio Inc including stock price, company news, executives, board members, and contact information.

Glympse Bio - BioSpace

How Glympse Bio oversubscribed their Series B funding amidst the ...

Loew also shares career advice for moving from pharma to biotech and how she pivoted the company's narrative during a funding round at the bottom of the ...

Sunbird Bio Completes Merger With Glympse Bio - 360Dx

NEW YORK – Singapore-based biotech firm Sunbird Bio said Wednesday that it has completed a merger with Cambridge, Massachusetts-based ...

Glympse Bio Inc. - BioCentury Company Profiles - BCIQ

Glympse Bio Inc. Headquarters: Cambridge, MA, United States of America. Website: N/A.

Glympse Bio Inc. - The Transatlantic Life Sciences Web Portal

Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine enabling rapid ...

Sunbird Bio and Glympse Bio Merge - Neurodex

Sunbird Bio, a pioneering biotechnology company focused on advancing the diagnosis and treatment of neurological disorders and early-stage cancer through ...

Glympse Bio company information, funding & investors | Dealroom.co

Glympse Bio, transforming disease detection and monitoring drug response. Here you'll find information about their funding, investors and team.

Glympse Bio, Inc - Cambridge - MapQuest

Get more information for Glympse Bio, Inc in Cambridge, MA. See reviews, map, get the address, and find directions.

Sunbird Bio, Glympse Bio merge for diagnostic development

Set to operate as Sunbird Bio, Inc., the newly merged entity will have its US headquarters in Cambridge, Massachusetts, and its operational ...

Glympse Bio Inc. | Institution outputs | Nature Index

Research. Date range: 1 September 2023 - 31 August 2024. No articles found. Glympse Bio Inc. did not contribute to ...

Faster tracking of treatment responses | MIT News

Glympse Bio uses synthetic biosensors to gather information on how ... The company believes its technology holds potential to transform disease ...

Glympse Bio - CB Insights

Glympse Bio operates as a biotechnology company. It enables noninvasive and predictive monitoring of multiple human diseases. Its technology uses engineered ...

Gilead and Glympse Bio Announce Strategic Collaboration for Use ...

Gilead Sciences Inc. (Nasdaq: GILD) and Glympse Bio, Inc., today announced that the companies have entered into a strategic collaboration in nonalcoholic ...